Anti-GD3 antibodies are targeting molecules for delivery of siRNA to melanoma
Melanoma is the most deadly form of skin cancers, with an incidence increasing more rapidly than any other malignant cancer in the past 40 years. Metastatic melanoma is resistant to conventional treatments, such as chemotherapy and radiation therapy. Our lab has previously demonstrated that Mcl-1 is...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en en |
| Published: |
2010
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1974/6018 |